Europe Onychomycosis Treatment Market Databank
The Onychomycosis Treatment market was valued at $4,200.0 Million in 2020, and is projected to reach $11,101.3 Million by 2029 growing at a CAGR of 11.47% from 2021 to 2029. Drug treatment segment is expected to be the highest contributor to this market, with $2,435.6 Million in 2020, and is anticipated to reach $6,460.7 Million by 2029, registering a CAGR of 11.51%.
- 1. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET, BY TREATMENT TYPE
- 1.1. OVERVIEW
- 1.2. DRUG TREATMENT
- 1.2.1 DRUG TREATMENT MARKET, BY REGION
- 1.2.1.1 North America Drug treatment Market, By Country
- 1.2.1.2 Europe Drug treatment Market, By Country
- 1.2.1.3 Asia-Pacific Drug treatment Market, By Country
- 1.2.1.4 Rest of World Drug treatment Market, By Country
- 1.3. TOPICAL THERAPY
- 1.3.1 TOPICAL THERAPY MARKET, BY REGION
- 1.3.1.1 North America Topical therapy Market, By Country
- 1.3.1.2 Europe Topical therapy Market, By Country
- 1.3.1.3 Asia-Pacific Topical therapy Market, By Country
- 1.3.1.4 Rest of World Topical therapy Market, By Country
- 2. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET, BY DRUG CLASS
- 2.1. OVERVIEW
- 2.2. ALLYLAMINE
- 2.2.1 ALLYLAMINE MARKET, BY REGION
- 2.2.1.1 North America Allylamine Market, By Country
- 2.2.1.2 Europe Allylamine Market, By Country
- 2.2.1.3 Asia-Pacific Allylamine Market, By Country
- 2.2.1.4 Rest of World Allylamine Market, By Country
- 2.3. AZOLE
- 2.3.1 AZOLE MARKET, BY REGION
- 2.3.1.1 North America Azole Market, By Country
- 2.3.1.2 Europe Azole Market, By Country
- 2.3.1.3 Asia-Pacific Azole Market, By Country
- 2.3.1.4 Rest of World Azole Market, By Country
- 2.4. GRISEOFULVIN
- 2.4.1 GRISEOFULVIN MARKET, BY REGION
- 2.4.1.1 North America Griseofulvin Market, By Country
- 2.4.1.2 Europe Griseofulvin Market, By Country
- 2.4.1.3 Asia-Pacific Griseofulvin Market, By Country
- 2.4.1.4 Rest of World Griseofulvin Market, By Country
- 2.5. OTHER DRUG CLASS
- 2.5.1 OTHER DRUG CLASS MARKET, BY REGION
- 2.5.1.1 North America Other Drug Class Market, By Country
- 2.5.1.2 Europe Other Drug Class Market, By Country
- 2.5.1.3 Asia-Pacific Other Drug Class Market, By Country
- 2.5.1.4 Rest of World Other Drug Class Market, By Country
- 3. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET, BY REGION
- 3.1. OVERVIEW
- 3.2. EUROPE
- 3.2.1 EUROPE ONYCHOMYCOSIS TREATMENT MARKET, BY TREATMENT TYPE
- 3.2.2 EUROPE ONYCHOMYCOSIS TREATMENT MARKET, BY DRUG CLASS
- 3.2.3 EUROPE ONYCHOMYCOSIS TREATMENT MARKET, BY COUNTRY
- 3.2.3.1 Germany
- 3.2.3.1.1 Germany Onychomycosis Treatment Market, By Treatment type
- 3.2.3.1.2 Germany Onychomycosis Treatment Market, By Drug Class
- 3.2.3.2 France
- 3.2.3.2.1 France Onychomycosis Treatment Market, By Treatment type
- 3.2.3.2.2 France Onychomycosis Treatment Market, By Drug Class
- 3.2.3.3 UK
- 3.2.3.3.1 UK Onychomycosis Treatment Market, By Treatment type
- 3.2.3.3.2 UK Onychomycosis Treatment Market, By Drug Class
- 3.2.3.4 Italy
- 3.2.3.4.1 Italy Onychomycosis Treatment Market, By Treatment type
- 3.2.3.4.2 Italy Onychomycosis Treatment Market, By Drug Class
- 3.2.3.5 Spain
- 3.2.3.5.1 Spain Onychomycosis Treatment Market, By Treatment type
- 3.2.3.5.2 Spain Onychomycosis Treatment Market, By Drug Class
- 3.2.3.6 Russia
- 3.2.3.6.1 Russia Onychomycosis Treatment Market, By Treatment type
- 3.2.3.6.2 Russia Onychomycosis Treatment Market, By Drug Class
- 3.2.3.7 Rest of Europe
- 3.2.3.7.1 Rest of Europe Onychomycosis Treatment Market, By Treatment type
- 3.2.3.7.2 Rest of Europe Onychomycosis Treatment Market, By Drug Class
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook